Global Antivenom Drugs Production, Demand and Key Producers, 2022-2028
Antivenom drugs are used to treat venomous bites and stings, usually preferable in high-toxicity cases. Antivenin, venom antiserum, and antivenom immunoglobulin are the different other names of antivenom drugs. These medications can potentially reverse the effects of snake bites, and generally, an adequate therapeutic dose is injected. Additionally, these medications also help in kidney dialysis, artificial respiration, prosthesis as well as rehabilitation services.
This report studies the global Antivenom Drugs production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Antivenom Drugs, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Antivenom Drugs that contribute to its increasing demand across many markets.
The global Antivenom Drugs market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Antivenom Drugs total production and demand, 2017-2028, (K Units)
Global Antivenom Drugs total production value, 2017-2028, (USD Million)
Global Antivenom Drugs production by region & country, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Antivenom Drugs consumption by region & country, CAGR, 2017-2028 & (K Units)
U.S. VS China: Antivenom Drugs domestic production, consumption, key domestic manufacturers and share
Global Antivenom Drugs production by manufacturer, production, price, value and market share 2017-2022, (USD Million) & (K Units)
Global Antivenom Drugs production by Type, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Antivenom Drugs production by Application production, value, CAGR, 2017-2028, (USD Million) & (K Units)
This reports profiles key players in the global Antivenom Drugs market based on the following parameters – headquarters, production locations, products portfolio, Antivenom Drugs revenue, sales, average price and gross margin, recent developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Antivenom Drugs market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Antivenom Drugs Market, By Region:
1. How big is the global Antivenom Drugs market?
2. What is the demand of the global Antivenom Drugs market?
3. What is the year over year growth of the global Antivenom Drugs market?
4. What is the production and production value of the global Antivenom Drugs market?
5. Who are the key producers in the global Antivenom Drugs market?
6. What are the growth factors driving the market demand?
This report studies the global Antivenom Drugs production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Antivenom Drugs, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Antivenom Drugs that contribute to its increasing demand across many markets.
The global Antivenom Drugs market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Antivenom Drugs total production and demand, 2017-2028, (K Units)
Global Antivenom Drugs total production value, 2017-2028, (USD Million)
Global Antivenom Drugs production by region & country, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Antivenom Drugs consumption by region & country, CAGR, 2017-2028 & (K Units)
U.S. VS China: Antivenom Drugs domestic production, consumption, key domestic manufacturers and share
Global Antivenom Drugs production by manufacturer, production, price, value and market share 2017-2022, (USD Million) & (K Units)
Global Antivenom Drugs production by Type, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Antivenom Drugs production by Application production, value, CAGR, 2017-2028, (USD Million) & (K Units)
This reports profiles key players in the global Antivenom Drugs market based on the following parameters – headquarters, production locations, products portfolio, Antivenom Drugs revenue, sales, average price and gross margin, recent developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Antivenom Drugs market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Antivenom Drugs Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Antineurotoxin
- Anticirculatory Toxin
- Antimixing Toxin
- Hospital
- Clinical Laboratory
- Field Rescue Station
- Other
- Bioclone Institute
- Pfizer Inc
- F. Hoffmann-La Roche Ltd
- Merck KGaA
- Rare Disease Therapeutics, Inc
- VINS Bioproducts Ltd
- BTG International Inc
- Incepta Pharma
- Bharat Serums and Vaccines Limited
- Hamilton Company
- B. Braun SE
- Cardinal Health
- BD
- Boston Scientific Corporation
- Alomone Labs
- Wyeth, LLC
- Serum Biotech
1. How big is the global Antivenom Drugs market?
2. What is the demand of the global Antivenom Drugs market?
3. What is the year over year growth of the global Antivenom Drugs market?
4. What is the production and production value of the global Antivenom Drugs market?
5. Who are the key producers in the global Antivenom Drugs market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Antivenom Drugs Introduction
1.2 World Antivenom Drugs Supply & Forecast
1.2.1 World Antivenom Drugs Production Value (2017 & 2021 & 2028)
1.2.2 World Antivenom Drugs Production (2017-2028)
1.2.3 World Antivenom Drugs Pricing Trends (2017-2028)
1.3 World Antivenom Drugs Production by Region
1.3.1 World Antivenom Drugs Production Value by Region (2017-2028)
1.3.2 World Antivenom Drugs Production by Region (2017-2028)
1.3.3 World Antivenom Drugs Average Price by Region (2017-2028)
1.3.4 North America Antivenom Drugs Production (2017-2028)
1.3.5 Europe Antivenom Drugs Production (2017-2028)
1.3.6 China Antivenom Drugs Production (2017-2028)
1.3.7 Japan Antivenom Drugs Production (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Antivenom Drugs Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Antivenom Drugs Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Antivenom Drugs Demand (2017-2028)
2.2 World Antivenom Drugs Consumption by Region
2.2.1 World Antivenom Drugs Consumption by Region (2017-2022)
2.2.2 World Antivenom Drugs Consumption Forecast by Region (2023-2028)
2.3 United States Antivenom Drugs Consumption (2017-2028)
2.4 China Antivenom Drugs Consumption (2017-2028)
2.5 Europe Antivenom Drugs Consumption (2017-2028)
2.6 Japan Antivenom Drugs Consumption (2017-2028)
2.7 South Korea Antivenom Drugs Consumption (2017-2028)
2.8 ASEAN Antivenom Drugs Consumption (2017-2028)
2.9 India Antivenom Drugs Consumption (2017-2028)
3 WORLD ANTIVENOM DRUGS MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Antivenom Drugs Production Value by Manufacturer (2017-2022)
3.2 World Antivenom Drugs Production by Manufacturer (2017-2022)
3.3 World Antivenom Drugs Average Price by Manufacturer (2017-2022)
3.4 Antivenom Drugs Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Antivenom Drugs Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Antivenom Drugs in 2021
3.5.3 Global Concentration Ratios (CR8) for Antivenom Drugs in 2021
3.6 Antivenom Drugs Market: Overall Company Footprint Analysis
3.6.1 Antivenom Drugs Market: Region Footprint
3.6.2 Antivenom Drugs Market: Company Product Type Footprint
3.6.3 Antivenom Drugs Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Antivenom Drugs Production Value Comparison
4.1.1 United States VS China: Antivenom Drugs Production Value Comparison (2017 & 2021 & 2028)
4.1.2 United States VS China: Antivenom Drugs Production Value Market Share Comparison (2017 & 2021 & 2028)
4.2 United States VS China: Antivenom Drugs Production Comparison
4.2.1 United States VS China: Antivenom Drugs Production Comparison (2017 & 2021 & 2028)
4.2.2 United States VS China: Antivenom Drugs Production Market Share Comparison (2017 & 2021 & 2028)
4.3 United States VS China: Antivenom Drugs Consumption Comparison
4.3.1 United States VS China: Antivenom Drugs Consumption Comparison (2017 & 2021 & 2028)
4.3.2 United States VS China: Antivenom Drugs Consumption Market Share Comparison (2017 & 2021 & 2028)
4.4 United States Antivenom Drugs Key Producers and Market Share, 2017-2022
4.4.1 Major Manufacturer of Antivenom Drugs in United States, Company Headquarters and Production Place (States, Country)
4.4.2 United States Antivenom Drugs Production Value by Domestic Manufacturer, (2017-2022)
4.4.3 United States Antivenom Drugs Production by Domestic Manufacturer, (2017-2022)
4.5 China Antivenom Drugs Key Producers and Market Share, 2017-2022
4.5.1 Major Manufacturer of Antivenom Drugs in China, Company Headquarters and Production Place (Province, Country)
4.5.2 China Antivenom Drugs Production Value by Domestic Manufacturer, (2017-2022)
4.5.3 China Antivenom Drugs Production by Domestic Manufacturer, (2017-2022)
4.6 Rest of World Antivenom Drugs Key Producers and Market Share, 2017-2022
4.6.1 Major Manufacturer of Antivenom Drugs in Rest of World, Company Headquarters and Production Place (State, Country)
4.6.2 Rest of World Antivenom Drugs Production Value by Domestic Manufacturer, (2017-2022)
4.6.3 Rest of World Antivenom Drugs Production by Domestic Manufacturer, (2017-2022)
5 MARKET ANALYSIS BY TYPE
5.1 World Antivenom Drugs Market Size Overview by Type: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Type
5.2.1 Antineurotoxin
5.2.2 Anticirculatory Toxin
5.2.3 Antimixing Toxin
5.3 Market Segment by Type
5.3.1 World Antivenom Drugs Production by Type (2017-2028)
5.3.2 World Antivenom Drugs Production Value by Type (2017-2028)
5.3.3 World Antivenom Drugs Average Price by Type (2017-2028)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Antivenom Drugs Market Size Overview by Application: 2017 VS 2021 VS 2028
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinical Laboratory
6.2.3 Field Rescue Station
6.2.4 Other
6.3 Market Segment by Application
6.3.1 World Antivenom Drugs Production by Application (2017-2028)
6.3.2 World Antivenom Drugs Production Value by Application (2017-2028)
6.3.3 World Antivenom Drugs Average Price by Application (2017-2028)
7 COMPANY PROFILES
7.1 Bioclone Institute
7.1.1 Bioclone Institute Details
7.1.2 Bioclone Institute Major Business
7.1.3 Bioclone Institute Antivenom Drugs Product and Services
7.1.4 Bioclone Institute Antivenom Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.1.5 Bioclone Institute Recent Developments/Updates
7.1.6 Bioclone Institute Competitive Strengths & Weaknesses
7.2 Pfizer Inc
7.2.1 Pfizer Inc Details
7.2.2 Pfizer Inc Major Business
7.2.3 Pfizer Inc Antivenom Drugs Product and Services
7.2.4 Pfizer Inc Antivenom Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.2.5 Pfizer Inc Recent Developments/Updates
7.2.6 Pfizer Inc Competitive Strengths & Weaknesses
7.3 F. Hoffmann-La Roche Ltd
7.3.1 F. Hoffmann-La Roche Ltd Details
7.3.2 F. Hoffmann-La Roche Ltd Major Business
7.3.3 F. Hoffmann-La Roche Ltd Antivenom Drugs Product and Services
7.3.4 F. Hoffmann-La Roche Ltd Antivenom Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.3.5 F. Hoffmann-La Roche Ltd Recent Developments/Updates
7.3.6 F. Hoffmann-La Roche Ltd Competitive Strengths & Weaknesses
7.4 Merck KGaA
7.4.1 Merck KGaA Details
7.4.2 Merck KGaA Major Business
7.4.3 Merck KGaA Antivenom Drugs Product and Services
7.4.4 Merck KGaA Antivenom Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.4.5 Merck KGaA Recent Developments/Updates
7.4.6 Merck KGaA Competitive Strengths & Weaknesses
7.5 Rare Disease Therapeutics, Inc
7.5.1 Rare Disease Therapeutics, Inc Details
7.5.2 Rare Disease Therapeutics, Inc Major Business
7.5.3 Rare Disease Therapeutics, Inc Antivenom Drugs Product and Services
7.5.4 Rare Disease Therapeutics, Inc Antivenom Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.5.5 Rare Disease Therapeutics, Inc Recent Developments/Updates
7.5.6 Rare Disease Therapeutics, Inc Competitive Strengths & Weaknesses
7.6 VINS Bioproducts Ltd
7.6.1 VINS Bioproducts Ltd Details
7.6.2 VINS Bioproducts Ltd Major Business
7.6.3 VINS Bioproducts Ltd Antivenom Drugs Product and Services
7.6.4 VINS Bioproducts Ltd Antivenom Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.6.5 VINS Bioproducts Ltd Recent Developments/Updates
7.6.6 VINS Bioproducts Ltd Competitive Strengths & Weaknesses
7.7 BTG International Inc
7.7.1 BTG International Inc Details
7.7.2 BTG International Inc Major Business
7.7.3 BTG International Inc Antivenom Drugs Product and Services
7.7.4 BTG International Inc Antivenom Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.7.5 BTG International Inc Recent Developments/Updates
7.7.6 BTG International Inc Competitive Strengths & Weaknesses
7.8 Incepta Pharma
7.8.1 Incepta Pharma Details
7.8.2 Incepta Pharma Major Business
7.8.3 Incepta Pharma Antivenom Drugs Product and Services
7.8.4 Incepta Pharma Antivenom Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.8.5 Incepta Pharma Recent Developments/Updates
7.8.6 Incepta Pharma Competitive Strengths & Weaknesses
7.9 Bharat Serums and Vaccines Limited
7.9.1 Bharat Serums and Vaccines Limited Details
7.9.2 Bharat Serums and Vaccines Limited Major Business
7.9.3 Bharat Serums and Vaccines Limited Antivenom Drugs Product and Services
7.9.4 Bharat Serums and Vaccines Limited Antivenom Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.9.5 Bharat Serums and Vaccines Limited Recent Developments/Updates
7.9.6 Bharat Serums and Vaccines Limited Competitive Strengths & Weaknesses
7.10 Hamilton Company
7.10.1 Hamilton Company Details
7.10.2 Hamilton Company Major Business
7.10.3 Hamilton Company Antivenom Drugs Product and Services
7.10.4 Hamilton Company Antivenom Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.10.5 Hamilton Company Recent Developments/Updates
7.10.6 Hamilton Company Competitive Strengths & Weaknesses
7.11 B. Braun SE
7.11.1 B. Braun SE Details
7.11.2 B. Braun SE Major Business
7.11.3 B. Braun SE Antivenom Drugs Product and Services
7.11.4 B. Braun SE Antivenom Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.11.5 B. Braun SE Recent Developments/Updates
7.11.6 B. Braun SE Competitive Strengths & Weaknesses
7.12 Cardinal Health
7.12.1 Cardinal Health Details
7.12.2 Cardinal Health Major Business
7.12.3 Cardinal Health Antivenom Drugs Product and Services
7.12.4 Cardinal Health Antivenom Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.12.5 Cardinal Health Recent Developments/Updates
7.12.6 Cardinal Health Competitive Strengths & Weaknesses
7.13 BD
7.13.1 BD Details
7.13.2 BD Major Business
7.13.3 BD Antivenom Drugs Product and Services
7.13.4 BD Antivenom Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.13.5 BD Recent Developments/Updates
7.13.6 BD Competitive Strengths & Weaknesses
7.14 Boston Scientific Corporation
7.14.1 Boston Scientific Corporation Details
7.14.2 Boston Scientific Corporation Major Business
7.14.3 Boston Scientific Corporation Antivenom Drugs Product and Services
7.14.4 Boston Scientific Corporation Antivenom Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.14.5 Boston Scientific Corporation Recent Developments/Updates
7.14.6 Boston Scientific Corporation Competitive Strengths & Weaknesses
7.15 Alomone Labs
7.15.1 Alomone Labs Details
7.15.2 Alomone Labs Major Business
7.15.3 Alomone Labs Antivenom Drugs Product and Services
7.15.4 Alomone Labs Antivenom Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.15.5 Alomone Labs Recent Developments/Updates
7.15.6 Alomone Labs Competitive Strengths & Weaknesses
7.16 Wyeth, LLC
7.16.1 Wyeth, LLC Details
7.16.2 Wyeth, LLC Major Business
7.16.3 Wyeth, LLC Antivenom Drugs Product and Services
7.16.4 Wyeth, LLC Antivenom Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.16.5 Wyeth, LLC Recent Developments/Updates
7.16.6 Wyeth, LLC Competitive Strengths & Weaknesses
7.17 Serum Biotech
7.17.1 Serum Biotech Details
7.17.2 Serum Biotech Major Business
7.17.3 Serum Biotech Antivenom Drugs Product and Services
7.17.4 Serum Biotech Antivenom Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.17.5 Serum Biotech Recent Developments/Updates
7.17.6 Serum Biotech Competitive Strengths & Weaknesses
8 RAW MATERIAL AND INDUSTRY CHAIN
8.1 Raw Material of Antivenom Drugs and Key Manufacturers
8.2 Antivenom Drugs Manufacturing Costs
8.3 Antivenom Drugs Production Process
8.4 Antivenom Drugs Industrial Chain
9 DISTRIBUTION CHANNEL ANALYSIS
9.1 Distribution Channel Breakdown for Antivenom Drugs Shipments (%): 2017-2028
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 Antivenom Drugs Typical Distributors
9.3 Antivenom Drugs Typical Customers
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
1.1 Antivenom Drugs Introduction
1.2 World Antivenom Drugs Supply & Forecast
1.2.1 World Antivenom Drugs Production Value (2017 & 2021 & 2028)
1.2.2 World Antivenom Drugs Production (2017-2028)
1.2.3 World Antivenom Drugs Pricing Trends (2017-2028)
1.3 World Antivenom Drugs Production by Region
1.3.1 World Antivenom Drugs Production Value by Region (2017-2028)
1.3.2 World Antivenom Drugs Production by Region (2017-2028)
1.3.3 World Antivenom Drugs Average Price by Region (2017-2028)
1.3.4 North America Antivenom Drugs Production (2017-2028)
1.3.5 Europe Antivenom Drugs Production (2017-2028)
1.3.6 China Antivenom Drugs Production (2017-2028)
1.3.7 Japan Antivenom Drugs Production (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Antivenom Drugs Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Antivenom Drugs Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Antivenom Drugs Demand (2017-2028)
2.2 World Antivenom Drugs Consumption by Region
2.2.1 World Antivenom Drugs Consumption by Region (2017-2022)
2.2.2 World Antivenom Drugs Consumption Forecast by Region (2023-2028)
2.3 United States Antivenom Drugs Consumption (2017-2028)
2.4 China Antivenom Drugs Consumption (2017-2028)
2.5 Europe Antivenom Drugs Consumption (2017-2028)
2.6 Japan Antivenom Drugs Consumption (2017-2028)
2.7 South Korea Antivenom Drugs Consumption (2017-2028)
2.8 ASEAN Antivenom Drugs Consumption (2017-2028)
2.9 India Antivenom Drugs Consumption (2017-2028)
3 WORLD ANTIVENOM DRUGS MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Antivenom Drugs Production Value by Manufacturer (2017-2022)
3.2 World Antivenom Drugs Production by Manufacturer (2017-2022)
3.3 World Antivenom Drugs Average Price by Manufacturer (2017-2022)
3.4 Antivenom Drugs Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Antivenom Drugs Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Antivenom Drugs in 2021
3.5.3 Global Concentration Ratios (CR8) for Antivenom Drugs in 2021
3.6 Antivenom Drugs Market: Overall Company Footprint Analysis
3.6.1 Antivenom Drugs Market: Region Footprint
3.6.2 Antivenom Drugs Market: Company Product Type Footprint
3.6.3 Antivenom Drugs Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Antivenom Drugs Production Value Comparison
4.1.1 United States VS China: Antivenom Drugs Production Value Comparison (2017 & 2021 & 2028)
4.1.2 United States VS China: Antivenom Drugs Production Value Market Share Comparison (2017 & 2021 & 2028)
4.2 United States VS China: Antivenom Drugs Production Comparison
4.2.1 United States VS China: Antivenom Drugs Production Comparison (2017 & 2021 & 2028)
4.2.2 United States VS China: Antivenom Drugs Production Market Share Comparison (2017 & 2021 & 2028)
4.3 United States VS China: Antivenom Drugs Consumption Comparison
4.3.1 United States VS China: Antivenom Drugs Consumption Comparison (2017 & 2021 & 2028)
4.3.2 United States VS China: Antivenom Drugs Consumption Market Share Comparison (2017 & 2021 & 2028)
4.4 United States Antivenom Drugs Key Producers and Market Share, 2017-2022
4.4.1 Major Manufacturer of Antivenom Drugs in United States, Company Headquarters and Production Place (States, Country)
4.4.2 United States Antivenom Drugs Production Value by Domestic Manufacturer, (2017-2022)
4.4.3 United States Antivenom Drugs Production by Domestic Manufacturer, (2017-2022)
4.5 China Antivenom Drugs Key Producers and Market Share, 2017-2022
4.5.1 Major Manufacturer of Antivenom Drugs in China, Company Headquarters and Production Place (Province, Country)
4.5.2 China Antivenom Drugs Production Value by Domestic Manufacturer, (2017-2022)
4.5.3 China Antivenom Drugs Production by Domestic Manufacturer, (2017-2022)
4.6 Rest of World Antivenom Drugs Key Producers and Market Share, 2017-2022
4.6.1 Major Manufacturer of Antivenom Drugs in Rest of World, Company Headquarters and Production Place (State, Country)
4.6.2 Rest of World Antivenom Drugs Production Value by Domestic Manufacturer, (2017-2022)
4.6.3 Rest of World Antivenom Drugs Production by Domestic Manufacturer, (2017-2022)
5 MARKET ANALYSIS BY TYPE
5.1 World Antivenom Drugs Market Size Overview by Type: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Type
5.2.1 Antineurotoxin
5.2.2 Anticirculatory Toxin
5.2.3 Antimixing Toxin
5.3 Market Segment by Type
5.3.1 World Antivenom Drugs Production by Type (2017-2028)
5.3.2 World Antivenom Drugs Production Value by Type (2017-2028)
5.3.3 World Antivenom Drugs Average Price by Type (2017-2028)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Antivenom Drugs Market Size Overview by Application: 2017 VS 2021 VS 2028
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinical Laboratory
6.2.3 Field Rescue Station
6.2.4 Other
6.3 Market Segment by Application
6.3.1 World Antivenom Drugs Production by Application (2017-2028)
6.3.2 World Antivenom Drugs Production Value by Application (2017-2028)
6.3.3 World Antivenom Drugs Average Price by Application (2017-2028)
7 COMPANY PROFILES
7.1 Bioclone Institute
7.1.1 Bioclone Institute Details
7.1.2 Bioclone Institute Major Business
7.1.3 Bioclone Institute Antivenom Drugs Product and Services
7.1.4 Bioclone Institute Antivenom Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.1.5 Bioclone Institute Recent Developments/Updates
7.1.6 Bioclone Institute Competitive Strengths & Weaknesses
7.2 Pfizer Inc
7.2.1 Pfizer Inc Details
7.2.2 Pfizer Inc Major Business
7.2.3 Pfizer Inc Antivenom Drugs Product and Services
7.2.4 Pfizer Inc Antivenom Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.2.5 Pfizer Inc Recent Developments/Updates
7.2.6 Pfizer Inc Competitive Strengths & Weaknesses
7.3 F. Hoffmann-La Roche Ltd
7.3.1 F. Hoffmann-La Roche Ltd Details
7.3.2 F. Hoffmann-La Roche Ltd Major Business
7.3.3 F. Hoffmann-La Roche Ltd Antivenom Drugs Product and Services
7.3.4 F. Hoffmann-La Roche Ltd Antivenom Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.3.5 F. Hoffmann-La Roche Ltd Recent Developments/Updates
7.3.6 F. Hoffmann-La Roche Ltd Competitive Strengths & Weaknesses
7.4 Merck KGaA
7.4.1 Merck KGaA Details
7.4.2 Merck KGaA Major Business
7.4.3 Merck KGaA Antivenom Drugs Product and Services
7.4.4 Merck KGaA Antivenom Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.4.5 Merck KGaA Recent Developments/Updates
7.4.6 Merck KGaA Competitive Strengths & Weaknesses
7.5 Rare Disease Therapeutics, Inc
7.5.1 Rare Disease Therapeutics, Inc Details
7.5.2 Rare Disease Therapeutics, Inc Major Business
7.5.3 Rare Disease Therapeutics, Inc Antivenom Drugs Product and Services
7.5.4 Rare Disease Therapeutics, Inc Antivenom Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.5.5 Rare Disease Therapeutics, Inc Recent Developments/Updates
7.5.6 Rare Disease Therapeutics, Inc Competitive Strengths & Weaknesses
7.6 VINS Bioproducts Ltd
7.6.1 VINS Bioproducts Ltd Details
7.6.2 VINS Bioproducts Ltd Major Business
7.6.3 VINS Bioproducts Ltd Antivenom Drugs Product and Services
7.6.4 VINS Bioproducts Ltd Antivenom Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.6.5 VINS Bioproducts Ltd Recent Developments/Updates
7.6.6 VINS Bioproducts Ltd Competitive Strengths & Weaknesses
7.7 BTG International Inc
7.7.1 BTG International Inc Details
7.7.2 BTG International Inc Major Business
7.7.3 BTG International Inc Antivenom Drugs Product and Services
7.7.4 BTG International Inc Antivenom Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.7.5 BTG International Inc Recent Developments/Updates
7.7.6 BTG International Inc Competitive Strengths & Weaknesses
7.8 Incepta Pharma
7.8.1 Incepta Pharma Details
7.8.2 Incepta Pharma Major Business
7.8.3 Incepta Pharma Antivenom Drugs Product and Services
7.8.4 Incepta Pharma Antivenom Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.8.5 Incepta Pharma Recent Developments/Updates
7.8.6 Incepta Pharma Competitive Strengths & Weaknesses
7.9 Bharat Serums and Vaccines Limited
7.9.1 Bharat Serums and Vaccines Limited Details
7.9.2 Bharat Serums and Vaccines Limited Major Business
7.9.3 Bharat Serums and Vaccines Limited Antivenom Drugs Product and Services
7.9.4 Bharat Serums and Vaccines Limited Antivenom Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.9.5 Bharat Serums and Vaccines Limited Recent Developments/Updates
7.9.6 Bharat Serums and Vaccines Limited Competitive Strengths & Weaknesses
7.10 Hamilton Company
7.10.1 Hamilton Company Details
7.10.2 Hamilton Company Major Business
7.10.3 Hamilton Company Antivenom Drugs Product and Services
7.10.4 Hamilton Company Antivenom Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.10.5 Hamilton Company Recent Developments/Updates
7.10.6 Hamilton Company Competitive Strengths & Weaknesses
7.11 B. Braun SE
7.11.1 B. Braun SE Details
7.11.2 B. Braun SE Major Business
7.11.3 B. Braun SE Antivenom Drugs Product and Services
7.11.4 B. Braun SE Antivenom Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.11.5 B. Braun SE Recent Developments/Updates
7.11.6 B. Braun SE Competitive Strengths & Weaknesses
7.12 Cardinal Health
7.12.1 Cardinal Health Details
7.12.2 Cardinal Health Major Business
7.12.3 Cardinal Health Antivenom Drugs Product and Services
7.12.4 Cardinal Health Antivenom Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.12.5 Cardinal Health Recent Developments/Updates
7.12.6 Cardinal Health Competitive Strengths & Weaknesses
7.13 BD
7.13.1 BD Details
7.13.2 BD Major Business
7.13.3 BD Antivenom Drugs Product and Services
7.13.4 BD Antivenom Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.13.5 BD Recent Developments/Updates
7.13.6 BD Competitive Strengths & Weaknesses
7.14 Boston Scientific Corporation
7.14.1 Boston Scientific Corporation Details
7.14.2 Boston Scientific Corporation Major Business
7.14.3 Boston Scientific Corporation Antivenom Drugs Product and Services
7.14.4 Boston Scientific Corporation Antivenom Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.14.5 Boston Scientific Corporation Recent Developments/Updates
7.14.6 Boston Scientific Corporation Competitive Strengths & Weaknesses
7.15 Alomone Labs
7.15.1 Alomone Labs Details
7.15.2 Alomone Labs Major Business
7.15.3 Alomone Labs Antivenom Drugs Product and Services
7.15.4 Alomone Labs Antivenom Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.15.5 Alomone Labs Recent Developments/Updates
7.15.6 Alomone Labs Competitive Strengths & Weaknesses
7.16 Wyeth, LLC
7.16.1 Wyeth, LLC Details
7.16.2 Wyeth, LLC Major Business
7.16.3 Wyeth, LLC Antivenom Drugs Product and Services
7.16.4 Wyeth, LLC Antivenom Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.16.5 Wyeth, LLC Recent Developments/Updates
7.16.6 Wyeth, LLC Competitive Strengths & Weaknesses
7.17 Serum Biotech
7.17.1 Serum Biotech Details
7.17.2 Serum Biotech Major Business
7.17.3 Serum Biotech Antivenom Drugs Product and Services
7.17.4 Serum Biotech Antivenom Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.17.5 Serum Biotech Recent Developments/Updates
7.17.6 Serum Biotech Competitive Strengths & Weaknesses
8 RAW MATERIAL AND INDUSTRY CHAIN
8.1 Raw Material of Antivenom Drugs and Key Manufacturers
8.2 Antivenom Drugs Manufacturing Costs
8.3 Antivenom Drugs Production Process
8.4 Antivenom Drugs Industrial Chain
9 DISTRIBUTION CHANNEL ANALYSIS
9.1 Distribution Channel Breakdown for Antivenom Drugs Shipments (%): 2017-2028
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 Antivenom Drugs Typical Distributors
9.3 Antivenom Drugs Typical Customers
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
LIST OF TABLES
Table 1. World Antivenom Drugs Production Value by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Antivenom Drugs Production Value by Region (2017-2022) & (USD Million)
Table 3. World Antivenom Drugs Production Value by Region (2023-2028) & (USD Million)
Table 4. World Antivenom Drugs Production Value Market Share by Region (2017-2022)
Table 5. World Antivenom Drugs Production Value Market Share by Region (2023-2028)
Table 6. World Antivenom Drugs Production by Region (2017-2022) & (K Units)
Table 7. World Antivenom Drugs Production by Region (2023-2028) & (K Units)
Table 8. World Antivenom Drugs Production Market Share by Region (2017-2022)
Table 9. World Antivenom Drugs Production Market Share by Region (2023-2028)
Table 10. World Antivenom Drugs Average Price by Region (2017-2022) & (US$/Unit)
Table 11. World Antivenom Drugs Average Price by Region (2023-2028) & (US$/Unit)
Table 12. Antivenom Drugs Major Market Trends
Table 13. World Antivenom Drugs Consumption Growth Rate Forecast by Region (2017 & 2021 & 2028) & (K Units)
Table 14. World Antivenom Drugs Consumption by Region (2017-2022) & (K Units)
Table 15. World Antivenom Drugs Consumption Forecast by Region (2023-2028) & (K Units)
Table 16. World Antivenom Drugs Production Value by Manufacturer (2017-2022) & (USD Million)
Table 17. Production Value Market Share of Key Antivenom Drugs Producers in 2021
Table 18. World Antivenom Drugs Production by Manufacturer (2017-2022) & (K Units)
Table 19. Production Market Share of Key Antivenom Drugs Producers in 2021
Table 20. World Antivenom Drugs Average Price by Manufacturer (2017-2022) & (US$/Unit)
Table 21. Global Antivenom Drugs Company Evaluation Quadrant
Table 22. World Antivenom Drugs Industry Rank of Major Manufacturers, Based on Production Value in 2021
Table 23. Head Office and Antivenom Drugs Production Site of Key Manufacturer
Table 24. Antivenom Drugs Market: Company Product Type Footprint
Table 25. Antivenom Drugs Market: Company Product Application Footprint
Table 26. Antivenom Drugs Competitive Factors
Table 27. Antivenom Drugs New Entrant and Capacity Expansion Plans
Table 28. Antivenom Drugs Mergers & Acquisitions Activity
Table 29. United States VS China Antivenom Drugs Production Value Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 30. United States VS China Antivenom Drugs Production Comparison, (2017 & 2021 & 2028) & (K Units)
Table 31. United States VS China Antivenom Drugs Consumption Comparison, (2017 & 2021 & 2028) & (K Units)
Table 32. Major Manufacturer of Antivenom Drugs in United States, Company Headquarters and Production Place (States, Country)
Table 33. United States Antivenom Drugs Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 34. United States Antivenom Drugs Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 35. United States Antivenom Drugs Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 36. United States Antivenom Drugs Production Market Share by Domestic Manufacturer, (2017-2022)
Table 37. Major Manufacturer of Antivenom Drugs in China, Company Headquarters and Production Place (Province, Country)
Table 38. China Antivenom Drugs Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 39. China Antivenom Drugs Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 40. China Antivenom Drugs Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 41. China Antivenom Drugs Production Market Share by Domestic Manufacturer, (2017-2022)
Table 42. Major Manufacturer of Antivenom Drugs in Rest of World, Company Headquarters and Production Place (State, Country)
Table 43. Rest of World Antivenom Drugs Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 44. Rest of World Antivenom Drugs Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 45. Rest of World Antivenom Drugs Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 46. Rest of World Antivenom Drugs Production Market Share by Domestic Manufacturer, (2017-2022)
Table 47. World Antivenom Drugs Production Value by Type, (USD Million), 2017 & 2021 & 2028
Table 48. World Antivenom Drugs Production by Type (2017-2022) & (K Units)
Table 49. World Antivenom Drugs Production by Type (2023-2028) & (K Units)
Table 50. World Antivenom Drugs Production Value by Type (2017-2022) & (USD Million)
Table 51. World Antivenom Drugs Production Value by Type (2023-2028) & (USD Million)
Table 52. World Antivenom Drugs Average Price by Type (2017-2022) & (US$/Unit)
Table 53. World Antivenom Drugs Average Price by Type (2023-2028) & (US$/Unit)
Table 54. World Antivenom Drugs Production Value by Application, (USD Million), 2017 & 2021 & 2028
Table 55. World Antivenom Drugs Production by Application (2017-2022) & (K Units)
Table 56. World Antivenom Drugs Production by Application (2023-2028) & (K Units)
Table 57. World Antivenom Drugs Production Value by Application (2017-2022) & (USD Million)
Table 58. World Antivenom Drugs Production Value by Application (2023-2028) & (USD Million)
Table 59. World Antivenom Drugs Average Price by Application (2017-2022) & (US$/Unit)
Table 60. World Antivenom Drugs Average Price by Application (2023-2028) & (US$/Unit)
Table 61. Bioclone Institute Basic Information, Manufacturing Base and Competitors
Table 62. Bioclone Institute Major Business
Table 63. Bioclone Institute Antivenom Drugs Product and Services
Table 64. Bioclone Institute Antivenom Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 65. Bioclone Institute Recent Developments/Updates
Table 66. Bioclone Institute Competitive Strengths & Weaknesses
Table 67. Pfizer Inc Basic Information, Manufacturing Base and Competitors
Table 68. Pfizer Inc Major Business
Table 69. Pfizer Inc Antivenom Drugs Product and Services
Table 70. Pfizer Inc Antivenom Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 71. Pfizer Inc Recent Developments/Updates
Table 72. Pfizer Inc Competitive Strengths & Weaknesses
Table 73. F. Hoffmann-La Roche Ltd Basic Information, Manufacturing Base and Competitors
Table 74. F. Hoffmann-La Roche Ltd Major Business
Table 75. F. Hoffmann-La Roche Ltd Antivenom Drugs Product and Services
Table 76. F. Hoffmann-La Roche Ltd Antivenom Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 77. F. Hoffmann-La Roche Ltd Recent Developments/Updates
Table 78. F. Hoffmann-La Roche Ltd Competitive Strengths & Weaknesses
Table 79. Merck KGaA Basic Information, Manufacturing Base and Competitors
Table 80. Merck KGaA Major Business
Table 81. Merck KGaA Antivenom Drugs Product and Services
Table 82. Merck KGaA Antivenom Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 83. Merck KGaA Recent Developments/Updates
Table 84. Merck KGaA Competitive Strengths & Weaknesses
Table 85. Rare Disease Therapeutics, Inc Basic Information, Manufacturing Base and Competitors
Table 86. Rare Disease Therapeutics, Inc Major Business
Table 87. Rare Disease Therapeutics, Inc Antivenom Drugs Product and Services
Table 88. Rare Disease Therapeutics, Inc Antivenom Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 89. Rare Disease Therapeutics, Inc Recent Developments/Updates
Table 90. Rare Disease Therapeutics, Inc Competitive Strengths & Weaknesses
Table 91. VINS Bioproducts Ltd Basic Information, Manufacturing Base and Competitors
Table 92. VINS Bioproducts Ltd Major Business
Table 93. VINS Bioproducts Ltd Antivenom Drugs Product and Services
Table 94. VINS Bioproducts Ltd Antivenom Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 95. VINS Bioproducts Ltd Recent Developments/Updates
Table 96. VINS Bioproducts Ltd Competitive Strengths & Weaknesses
Table 97. BTG International Inc Basic Information, Manufacturing Base and Competitors
Table 98. BTG International Inc Major Business
Table 99. BTG International Inc Antivenom Drugs Product and Services
Table 100. BTG International Inc Antivenom Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 101. BTG International Inc Recent Developments/Updates
Table 102. BTG International Inc Competitive Strengths & Weaknesses
Table 103. Incepta Pharma Basic Information, Manufacturing Base and Competitors
Table 104. Incepta Pharma Major Business
Table 105. Incepta Pharma Antivenom Drugs Product and Services
Table 106. Incepta Pharma Antivenom Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 107. Incepta Pharma Recent Developments/Updates
Table 108. Incepta Pharma Competitive Strengths & Weaknesses
Table 109. Bharat Serums and Vaccines Limited Basic Information, Manufacturing Base and Competitors
Table 110. Bharat Serums and Vaccines Limited Major Business
Table 111. Bharat Serums and Vaccines Limited Antivenom Drugs Product and Services
Table 112. Bharat Serums and Vaccines Limited Antivenom Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 113. Bharat Serums and Vaccines Limited Recent Developments/Updates
Table 114. Bharat Serums and Vaccines Limited Competitive Strengths & Weaknesses
Table 115. Hamilton Company Basic Information, Manufacturing Base and Competitors
Table 116. Hamilton Company Major Business
Table 117. Hamilton Company Antivenom Drugs Product and Services
Table 118. Hamilton Company Antivenom Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 119. Hamilton Company Recent Developments/Updates
Table 120. Hamilton Company Competitive Strengths & Weaknesses
Table 121. B. Braun SE Basic Information, Manufacturing Base and Competitors
Table 122. B. Braun SE Major Business
Table 123. B. Braun SE Antivenom Drugs Product and Services
Table 124. B. Braun SE Antivenom Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 125. B. Braun SE Recent Developments/Updates
Table 126. B. Braun SE Competitive Strengths & Weaknesses
Table 127. Cardinal Health Basic Information, Manufacturing Base and Competitors
Table 128. Cardinal Health Major Business
Table 129. Cardinal Health Antivenom Drugs Product and Services
Table 130. Cardinal Health Antivenom Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 131. Cardinal Health Recent Developments/Updates
Table 132. Cardinal Health Competitive Strengths & Weaknesses
Table 133. BD Basic Information, Manufacturing Base and Competitors
Table 134. BD Major Business
Table 135. BD Antivenom Drugs Product and Services
Table 136. BD Antivenom Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 137. BD Recent Developments/Updates
Table 138. BD Competitive Strengths & Weaknesses
Table 139. Boston Scientific Corporation Basic Information, Manufacturing Base and Competitors
Table 140. Boston Scientific Corporation Major Business
Table 141. Boston Scientific Corporation Antivenom Drugs Product and Services
Table 142. Boston Scientific Corporation Antivenom Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 143. Boston Scientific Corporation Recent Developments/Updates
Table 144. Boston Scientific Corporation Competitive Strengths & Weaknesses
Table 145. Alomone Labs Basic Information, Manufacturing Base and Competitors
Table 146. Alomone Labs Major Business
Table 147. Alomone Labs Antivenom Drugs Product and Services
Table 148. Alomone Labs Antivenom Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 149. Alomone Labs Recent Developments/Updates
Table 150. Alomone Labs Competitive Strengths & Weaknesses
Table 151. Wyeth, LLC Basic Information, Manufacturing Base and Competitors
Table 152. Wyeth, LLC Major Business
Table 153. Wyeth, LLC Antivenom Drugs Product and Services
Table 154. Wyeth, LLC Antivenom Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 155. Wyeth, LLC Recent Developments/Updates
Table 156. Serum Biotech Basic Information, Manufacturing Base and Competitors
Table 157. Serum Biotech Major Business
Table 158. Serum Biotech Antivenom Drugs Product and Services
Table 159. Serum Biotech Antivenom Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 160. Antivenom Drugs Raw Material
Table 161. Key Manufacturers of Antivenom Drugs Raw Materials
Table 162. Antivenom Drugs Typical Distributors
Table 163. Antivenom Drugs Typical Customers
Table 1. World Antivenom Drugs Production Value by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Antivenom Drugs Production Value by Region (2017-2022) & (USD Million)
Table 3. World Antivenom Drugs Production Value by Region (2023-2028) & (USD Million)
Table 4. World Antivenom Drugs Production Value Market Share by Region (2017-2022)
Table 5. World Antivenom Drugs Production Value Market Share by Region (2023-2028)
Table 6. World Antivenom Drugs Production by Region (2017-2022) & (K Units)
Table 7. World Antivenom Drugs Production by Region (2023-2028) & (K Units)
Table 8. World Antivenom Drugs Production Market Share by Region (2017-2022)
Table 9. World Antivenom Drugs Production Market Share by Region (2023-2028)
Table 10. World Antivenom Drugs Average Price by Region (2017-2022) & (US$/Unit)
Table 11. World Antivenom Drugs Average Price by Region (2023-2028) & (US$/Unit)
Table 12. Antivenom Drugs Major Market Trends
Table 13. World Antivenom Drugs Consumption Growth Rate Forecast by Region (2017 & 2021 & 2028) & (K Units)
Table 14. World Antivenom Drugs Consumption by Region (2017-2022) & (K Units)
Table 15. World Antivenom Drugs Consumption Forecast by Region (2023-2028) & (K Units)
Table 16. World Antivenom Drugs Production Value by Manufacturer (2017-2022) & (USD Million)
Table 17. Production Value Market Share of Key Antivenom Drugs Producers in 2021
Table 18. World Antivenom Drugs Production by Manufacturer (2017-2022) & (K Units)
Table 19. Production Market Share of Key Antivenom Drugs Producers in 2021
Table 20. World Antivenom Drugs Average Price by Manufacturer (2017-2022) & (US$/Unit)
Table 21. Global Antivenom Drugs Company Evaluation Quadrant
Table 22. World Antivenom Drugs Industry Rank of Major Manufacturers, Based on Production Value in 2021
Table 23. Head Office and Antivenom Drugs Production Site of Key Manufacturer
Table 24. Antivenom Drugs Market: Company Product Type Footprint
Table 25. Antivenom Drugs Market: Company Product Application Footprint
Table 26. Antivenom Drugs Competitive Factors
Table 27. Antivenom Drugs New Entrant and Capacity Expansion Plans
Table 28. Antivenom Drugs Mergers & Acquisitions Activity
Table 29. United States VS China Antivenom Drugs Production Value Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 30. United States VS China Antivenom Drugs Production Comparison, (2017 & 2021 & 2028) & (K Units)
Table 31. United States VS China Antivenom Drugs Consumption Comparison, (2017 & 2021 & 2028) & (K Units)
Table 32. Major Manufacturer of Antivenom Drugs in United States, Company Headquarters and Production Place (States, Country)
Table 33. United States Antivenom Drugs Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 34. United States Antivenom Drugs Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 35. United States Antivenom Drugs Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 36. United States Antivenom Drugs Production Market Share by Domestic Manufacturer, (2017-2022)
Table 37. Major Manufacturer of Antivenom Drugs in China, Company Headquarters and Production Place (Province, Country)
Table 38. China Antivenom Drugs Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 39. China Antivenom Drugs Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 40. China Antivenom Drugs Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 41. China Antivenom Drugs Production Market Share by Domestic Manufacturer, (2017-2022)
Table 42. Major Manufacturer of Antivenom Drugs in Rest of World, Company Headquarters and Production Place (State, Country)
Table 43. Rest of World Antivenom Drugs Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 44. Rest of World Antivenom Drugs Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 45. Rest of World Antivenom Drugs Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 46. Rest of World Antivenom Drugs Production Market Share by Domestic Manufacturer, (2017-2022)
Table 47. World Antivenom Drugs Production Value by Type, (USD Million), 2017 & 2021 & 2028
Table 48. World Antivenom Drugs Production by Type (2017-2022) & (K Units)
Table 49. World Antivenom Drugs Production by Type (2023-2028) & (K Units)
Table 50. World Antivenom Drugs Production Value by Type (2017-2022) & (USD Million)
Table 51. World Antivenom Drugs Production Value by Type (2023-2028) & (USD Million)
Table 52. World Antivenom Drugs Average Price by Type (2017-2022) & (US$/Unit)
Table 53. World Antivenom Drugs Average Price by Type (2023-2028) & (US$/Unit)
Table 54. World Antivenom Drugs Production Value by Application, (USD Million), 2017 & 2021 & 2028
Table 55. World Antivenom Drugs Production by Application (2017-2022) & (K Units)
Table 56. World Antivenom Drugs Production by Application (2023-2028) & (K Units)
Table 57. World Antivenom Drugs Production Value by Application (2017-2022) & (USD Million)
Table 58. World Antivenom Drugs Production Value by Application (2023-2028) & (USD Million)
Table 59. World Antivenom Drugs Average Price by Application (2017-2022) & (US$/Unit)
Table 60. World Antivenom Drugs Average Price by Application (2023-2028) & (US$/Unit)
Table 61. Bioclone Institute Basic Information, Manufacturing Base and Competitors
Table 62. Bioclone Institute Major Business
Table 63. Bioclone Institute Antivenom Drugs Product and Services
Table 64. Bioclone Institute Antivenom Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 65. Bioclone Institute Recent Developments/Updates
Table 66. Bioclone Institute Competitive Strengths & Weaknesses
Table 67. Pfizer Inc Basic Information, Manufacturing Base and Competitors
Table 68. Pfizer Inc Major Business
Table 69. Pfizer Inc Antivenom Drugs Product and Services
Table 70. Pfizer Inc Antivenom Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 71. Pfizer Inc Recent Developments/Updates
Table 72. Pfizer Inc Competitive Strengths & Weaknesses
Table 73. F. Hoffmann-La Roche Ltd Basic Information, Manufacturing Base and Competitors
Table 74. F. Hoffmann-La Roche Ltd Major Business
Table 75. F. Hoffmann-La Roche Ltd Antivenom Drugs Product and Services
Table 76. F. Hoffmann-La Roche Ltd Antivenom Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 77. F. Hoffmann-La Roche Ltd Recent Developments/Updates
Table 78. F. Hoffmann-La Roche Ltd Competitive Strengths & Weaknesses
Table 79. Merck KGaA Basic Information, Manufacturing Base and Competitors
Table 80. Merck KGaA Major Business
Table 81. Merck KGaA Antivenom Drugs Product and Services
Table 82. Merck KGaA Antivenom Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 83. Merck KGaA Recent Developments/Updates
Table 84. Merck KGaA Competitive Strengths & Weaknesses
Table 85. Rare Disease Therapeutics, Inc Basic Information, Manufacturing Base and Competitors
Table 86. Rare Disease Therapeutics, Inc Major Business
Table 87. Rare Disease Therapeutics, Inc Antivenom Drugs Product and Services
Table 88. Rare Disease Therapeutics, Inc Antivenom Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 89. Rare Disease Therapeutics, Inc Recent Developments/Updates
Table 90. Rare Disease Therapeutics, Inc Competitive Strengths & Weaknesses
Table 91. VINS Bioproducts Ltd Basic Information, Manufacturing Base and Competitors
Table 92. VINS Bioproducts Ltd Major Business
Table 93. VINS Bioproducts Ltd Antivenom Drugs Product and Services
Table 94. VINS Bioproducts Ltd Antivenom Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 95. VINS Bioproducts Ltd Recent Developments/Updates
Table 96. VINS Bioproducts Ltd Competitive Strengths & Weaknesses
Table 97. BTG International Inc Basic Information, Manufacturing Base and Competitors
Table 98. BTG International Inc Major Business
Table 99. BTG International Inc Antivenom Drugs Product and Services
Table 100. BTG International Inc Antivenom Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 101. BTG International Inc Recent Developments/Updates
Table 102. BTG International Inc Competitive Strengths & Weaknesses
Table 103. Incepta Pharma Basic Information, Manufacturing Base and Competitors
Table 104. Incepta Pharma Major Business
Table 105. Incepta Pharma Antivenom Drugs Product and Services
Table 106. Incepta Pharma Antivenom Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 107. Incepta Pharma Recent Developments/Updates
Table 108. Incepta Pharma Competitive Strengths & Weaknesses
Table 109. Bharat Serums and Vaccines Limited Basic Information, Manufacturing Base and Competitors
Table 110. Bharat Serums and Vaccines Limited Major Business
Table 111. Bharat Serums and Vaccines Limited Antivenom Drugs Product and Services
Table 112. Bharat Serums and Vaccines Limited Antivenom Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 113. Bharat Serums and Vaccines Limited Recent Developments/Updates
Table 114. Bharat Serums and Vaccines Limited Competitive Strengths & Weaknesses
Table 115. Hamilton Company Basic Information, Manufacturing Base and Competitors
Table 116. Hamilton Company Major Business
Table 117. Hamilton Company Antivenom Drugs Product and Services
Table 118. Hamilton Company Antivenom Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 119. Hamilton Company Recent Developments/Updates
Table 120. Hamilton Company Competitive Strengths & Weaknesses
Table 121. B. Braun SE Basic Information, Manufacturing Base and Competitors
Table 122. B. Braun SE Major Business
Table 123. B. Braun SE Antivenom Drugs Product and Services
Table 124. B. Braun SE Antivenom Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 125. B. Braun SE Recent Developments/Updates
Table 126. B. Braun SE Competitive Strengths & Weaknesses
Table 127. Cardinal Health Basic Information, Manufacturing Base and Competitors
Table 128. Cardinal Health Major Business
Table 129. Cardinal Health Antivenom Drugs Product and Services
Table 130. Cardinal Health Antivenom Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 131. Cardinal Health Recent Developments/Updates
Table 132. Cardinal Health Competitive Strengths & Weaknesses
Table 133. BD Basic Information, Manufacturing Base and Competitors
Table 134. BD Major Business
Table 135. BD Antivenom Drugs Product and Services
Table 136. BD Antivenom Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 137. BD Recent Developments/Updates
Table 138. BD Competitive Strengths & Weaknesses
Table 139. Boston Scientific Corporation Basic Information, Manufacturing Base and Competitors
Table 140. Boston Scientific Corporation Major Business
Table 141. Boston Scientific Corporation Antivenom Drugs Product and Services
Table 142. Boston Scientific Corporation Antivenom Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 143. Boston Scientific Corporation Recent Developments/Updates
Table 144. Boston Scientific Corporation Competitive Strengths & Weaknesses
Table 145. Alomone Labs Basic Information, Manufacturing Base and Competitors
Table 146. Alomone Labs Major Business
Table 147. Alomone Labs Antivenom Drugs Product and Services
Table 148. Alomone Labs Antivenom Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 149. Alomone Labs Recent Developments/Updates
Table 150. Alomone Labs Competitive Strengths & Weaknesses
Table 151. Wyeth, LLC Basic Information, Manufacturing Base and Competitors
Table 152. Wyeth, LLC Major Business
Table 153. Wyeth, LLC Antivenom Drugs Product and Services
Table 154. Wyeth, LLC Antivenom Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 155. Wyeth, LLC Recent Developments/Updates
Table 156. Serum Biotech Basic Information, Manufacturing Base and Competitors
Table 157. Serum Biotech Major Business
Table 158. Serum Biotech Antivenom Drugs Product and Services
Table 159. Serum Biotech Antivenom Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 160. Antivenom Drugs Raw Material
Table 161. Key Manufacturers of Antivenom Drugs Raw Materials
Table 162. Antivenom Drugs Typical Distributors
Table 163. Antivenom Drugs Typical Customers
LIST OF FIGURES
Figure 1. Antivenom Drugs Picture
Figure 2. World Antivenom Drugs Production Value: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Antivenom Drugs Production Value and Forecast (2017-2028) & (USD Million)
Figure 4. World Antivenom Drugs Production (2017-2028) & (K Units)
Figure 5. World Antivenom Drugs Average Price (2017-2028) & (US$/Unit)
Figure 6. World Antivenom Drugs Production Value Market Share by Region (2017-2028)
Figure 7. World Antivenom Drugs Production Market Share by Region (2017-2028)
Figure 8. North America Antivenom Drugs Production (2017-2028) & (K Units)
Figure 9. Europe Antivenom Drugs Production (2017-2028) & (K Units)
Figure 10. China Antivenom Drugs Production (2017-2028) & (K Units)
Figure 11. Japan Antivenom Drugs Production (2017-2028) & (K Units)
Figure 12. Antivenom Drugs Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Antivenom Drugs Demand (2017-2028) & (K Units)
Figure 15. World Antivenom Drugs Consumption Market Share by Region (2017-2028)
Figure 16. United States Antivenom Drugs Consumption (2017-2028) & (K Units)
Figure 17. China Antivenom Drugs Consumption (2017-2028) & (K Units)
Figure 18. Europe Antivenom Drugs Consumption (2017-2028) & (K Units)
Figure 19. Japan Antivenom Drugs Consumption (2017-2028) & (K Units)
Figure 20. South Korea Antivenom Drugs Consumption (2017-2028) & (K Units)
Figure 21. ASEAN Antivenom Drugs Consumption (2017-2028) & (K Units)
Figure 22. India Antivenom Drugs Consumption (2017-2028) & (K Units)
Figure 23. Producer Shipments of Antivenom Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2021
Figure 24. Global Four-firm Concentration Ratios (CR4) for Antivenom Drugs Markets in 2021
Figure 25. Global Four-firm Concentration Ratios (CR8) for Antivenom Drugs Markets in 2021
Figure 26. United States VS China: Antivenom Drugs Production Value Market Share Comparison (2017 & 2021 & 2028)
Figure 27. United States VS China: Antivenom Drugs Production Market Share Comparison (2017 & 2021 & 2028)
Figure 28. United States VS China: Antivenom Drugs Consumption Market Share Comparison (2017 & 2021 & 2028)
Figure 29. Key Producers and Market Share of Antivenom Drugs in United States
Figure 30. Key Producers and Market Share of Antivenom Drugs in China
Figure 31. Key Producers and Market Share of Antivenom Drugs in Rest of World
Figure 32. World Antivenom Drugs Production Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 33. World Antivenom Drugs Production Value Market Share by Type in 2021
Figure 34. Antineurotoxin
Figure 35. Anticirculatory Toxin
Figure 36. Antimixing Toxin
Figure 37. World Antivenom Drugs Production Market Share by Type (2017-2028)
Figure 38. World Antivenom Drugs Production Value Market Share by Type (2017-2028)
Figure 39. World Antivenom Drugs Average Price by Type (2017-2028) & (US$/Unit)
Figure 40. World Antivenom Drugs Production Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 41. World Antivenom Drugs Production Value Market Share by Application in 2021
Figure 42. Hospital
Figure 43. Clinical Laboratory
Figure 44. Field Rescue Station
Figure 45. Other
Figure 46. World Antivenom Drugs Production Market Share by Application (2017-2028)
Figure 47. World Antivenom Drugs Production Value Market Share by Application (2017-2028)
Figure 48. World Antivenom Drugs Average Price by Application (2017-2028) & (US$/Unit)
Figure 49. Manufacturing Cost Structure Analysis of Antivenom Drugs in 2021
Figure 50. Manufacturing Process Analysis of Antivenom Drugs
Figure 51. Antivenom Drugs Industrial Chain
Figure 52. Distribution Channel Breakdown for Antivenom Drugs Shipments (%): 2017-2028
Figure 53. Direct Channel Pros & Cons
Figure 54. Indirect Channel Pros & Cons
Figure 55. Methodology
Figure 56. Research Process and Data Source
Figure 1. Antivenom Drugs Picture
Figure 2. World Antivenom Drugs Production Value: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Antivenom Drugs Production Value and Forecast (2017-2028) & (USD Million)
Figure 4. World Antivenom Drugs Production (2017-2028) & (K Units)
Figure 5. World Antivenom Drugs Average Price (2017-2028) & (US$/Unit)
Figure 6. World Antivenom Drugs Production Value Market Share by Region (2017-2028)
Figure 7. World Antivenom Drugs Production Market Share by Region (2017-2028)
Figure 8. North America Antivenom Drugs Production (2017-2028) & (K Units)
Figure 9. Europe Antivenom Drugs Production (2017-2028) & (K Units)
Figure 10. China Antivenom Drugs Production (2017-2028) & (K Units)
Figure 11. Japan Antivenom Drugs Production (2017-2028) & (K Units)
Figure 12. Antivenom Drugs Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Antivenom Drugs Demand (2017-2028) & (K Units)
Figure 15. World Antivenom Drugs Consumption Market Share by Region (2017-2028)
Figure 16. United States Antivenom Drugs Consumption (2017-2028) & (K Units)
Figure 17. China Antivenom Drugs Consumption (2017-2028) & (K Units)
Figure 18. Europe Antivenom Drugs Consumption (2017-2028) & (K Units)
Figure 19. Japan Antivenom Drugs Consumption (2017-2028) & (K Units)
Figure 20. South Korea Antivenom Drugs Consumption (2017-2028) & (K Units)
Figure 21. ASEAN Antivenom Drugs Consumption (2017-2028) & (K Units)
Figure 22. India Antivenom Drugs Consumption (2017-2028) & (K Units)
Figure 23. Producer Shipments of Antivenom Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2021
Figure 24. Global Four-firm Concentration Ratios (CR4) for Antivenom Drugs Markets in 2021
Figure 25. Global Four-firm Concentration Ratios (CR8) for Antivenom Drugs Markets in 2021
Figure 26. United States VS China: Antivenom Drugs Production Value Market Share Comparison (2017 & 2021 & 2028)
Figure 27. United States VS China: Antivenom Drugs Production Market Share Comparison (2017 & 2021 & 2028)
Figure 28. United States VS China: Antivenom Drugs Consumption Market Share Comparison (2017 & 2021 & 2028)
Figure 29. Key Producers and Market Share of Antivenom Drugs in United States
Figure 30. Key Producers and Market Share of Antivenom Drugs in China
Figure 31. Key Producers and Market Share of Antivenom Drugs in Rest of World
Figure 32. World Antivenom Drugs Production Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 33. World Antivenom Drugs Production Value Market Share by Type in 2021
Figure 34. Antineurotoxin
Figure 35. Anticirculatory Toxin
Figure 36. Antimixing Toxin
Figure 37. World Antivenom Drugs Production Market Share by Type (2017-2028)
Figure 38. World Antivenom Drugs Production Value Market Share by Type (2017-2028)
Figure 39. World Antivenom Drugs Average Price by Type (2017-2028) & (US$/Unit)
Figure 40. World Antivenom Drugs Production Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 41. World Antivenom Drugs Production Value Market Share by Application in 2021
Figure 42. Hospital
Figure 43. Clinical Laboratory
Figure 44. Field Rescue Station
Figure 45. Other
Figure 46. World Antivenom Drugs Production Market Share by Application (2017-2028)
Figure 47. World Antivenom Drugs Production Value Market Share by Application (2017-2028)
Figure 48. World Antivenom Drugs Average Price by Application (2017-2028) & (US$/Unit)
Figure 49. Manufacturing Cost Structure Analysis of Antivenom Drugs in 2021
Figure 50. Manufacturing Process Analysis of Antivenom Drugs
Figure 51. Antivenom Drugs Industrial Chain
Figure 52. Distribution Channel Breakdown for Antivenom Drugs Shipments (%): 2017-2028
Figure 53. Direct Channel Pros & Cons
Figure 54. Indirect Channel Pros & Cons
Figure 55. Methodology
Figure 56. Research Process and Data Source
